These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6242320)

  • 21. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area.
    Rosato A; Zambon A; Macino B; Mandruzzato S; Bronte V; Milan G; Zanovello P; Collavo D
    Int J Cancer; 1996 Mar; 65(6):847-51. PubMed ID: 8631602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biology of T-cells studied using monoclonal antibodies. I. Subpopulations of T-cell and monoclonal antibodies].
    Rupniewska ZM
    Przegl Lek; 1984; 41(8):529-35. PubMed ID: 6240076
    [No Abstract]   [Full Text] [Related]  

  • 23. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 24. The in vivo role of leukocyte function-associated antigen-1 in cytotoxic cell activity against tumors induced by Moloney-murine sarcoma/leukemia retroviral complex.
    Rosato A; Bronte V; Pollis F; Mandruzzato S; Zambon A; Zanovello P; Collavo D
    Leukemia; 1992; 6 Suppl 3():166S-167S. PubMed ID: 1602816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of recombinant human interleukin 2 on the growth of a BALB/c sarcoma induced by Moloney murine sarcoma virus.
    Mitsunaga S; Kimura H; Yamaguchi Y; Mikata A
    Jpn J Cancer Res; 1988 Aug; 79(8):965-72. PubMed ID: 3141331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy.
    Diehl L; den Boer AT; Schoenberger SP; van der Voort EI; Schumacher TN; Melief CJ; Offringa R; Toes RE
    Nat Med; 1999 Jul; 5(7):774-9. PubMed ID: 10395322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific and non-specific responses in host resistance to tumors.
    Baldwin RW
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):419-28. PubMed ID: 6398929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine.
    Kim JJ; Trivedi NN; Wilson DM; Mahalingam S; Morrison L; Tsai A; Chattergoon MA; Dang K; Patel M; Ahn L; Boyer JD; Chalian AA; Schoemaker H; Kieber-Emmons T; Agadjanyan MA; Weiner DB
    Oncogene; 1998 Dec; 17(24):3125-35. PubMed ID: 9872328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of T-helper lymphocytes in priming for experimental autoimmune glomerulonephritis in the BN rat.
    Reynolds J; Sallie BA; Syrganis C; Pusey CD
    J Autoimmun; 1993 Oct; 6(5):571-85. PubMed ID: 8240662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and target.
    Segal JG; Lee NC; Tsung YL; Norton JA; Tsung K
    Cancer Res; 2002 Aug; 62(16):4696-703. PubMed ID: 12183428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    Leclerc JC; Cantor H
    J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic suppression of carcinogenesis in spontaneously hypertensive rats (SHR) with T cell depression.
    Takeichi N; Ba D; Koga Y; Kobayashi H
    J Immunol; 1983 Jan; 130(1):501-5. PubMed ID: 6600196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities.
    Yu Z; Ren P; Zhang X; Zhang T; Ma B
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1065-71. PubMed ID: 19671026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T helper target cell DNA fragmentation through a CD4-positive T suppressor cell clone inducing specific unresponsiveness.
    Becker C; Konur A; Rademaekers A; Kodelja V; Partenheimer A; Pauels HG; Kölsch E
    Cell Immunol; 1994 Feb; 153(2):505-15. PubMed ID: 7907005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.
    Bui JD; Uppaluri R; Hsieh CS; Schreiber RD
    Cancer Res; 2006 Jul; 66(14):7301-9. PubMed ID: 16849580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of lymphocytes and antibodies derived from aging and adult rats bearing a MC-induced tumor in the syngeneic ADCC test.
    Nowak JJ; Ziółkowska M; Ryzewska A
    Neoplasma; 1987; 34(6):703-11. PubMed ID: 3431610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.